61 related articles for article (PubMed ID: 25617393)
1. Specimen Age Stability for Human Papilloma Virus DNA Testing Using BD SurePath.
Kubik MJ; Permenter T; Saremian J
Lab Med; 2015; 46(1):51-4; quiz e13. PubMed ID: 25617393
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
[TBL] [Abstract][Full Text] [Related]
3. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
[TBL] [Abstract][Full Text] [Related]
4. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
[TBL] [Abstract][Full Text] [Related]
5. Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.
Tardif KD; Pyne MT; Malmberg E; Lunt TC; Schlaberg R
PLoS One; 2016; 11(2):e0149611. PubMed ID: 26905067
[TBL] [Abstract][Full Text] [Related]
6. SurePath Specimens Versus ThinPrep Specimen Types on the COBAS 4800 Platform: High-Risk HPV Status and Cytology Correlation in an Ethnically Diverse Bronx Population.
Naeem RC; Goldstein DY; Einstein MH; Ramos Rivera G; Schlesinger K; Khader SN; Suhrland M; Fox AS
Lab Med; 2017 Aug; 48(3):207-213. PubMed ID: 28379422
[TBL] [Abstract][Full Text] [Related]
7. Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.
Gilbert L; Oates E; Ratnam S
J Clin Microbiol; 2013 Oct; 51(10):3412-4. PubMed ID: 23903540
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid.
Krevolin MD; Hardy D; Pane J; Aslam S; Behrens CM
J Mol Diagn; 2017 Mar; 19(2):288-294. PubMed ID: 28041871
[TBL] [Abstract][Full Text] [Related]
9. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
[TBL] [Abstract][Full Text] [Related]
10. A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing.
Sultana F; Gertig DM; Wrede CD; English DR; Simpson JA; Drennan KT; Brotherton JM; Phillips G; Heley S; Castle PE; Saville M
J Clin Virol; 2015 Aug; 69():210-3. PubMed ID: 26209409
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
[TBL] [Abstract][Full Text] [Related]
15. Assessment of human papilloma virus infection in adult laryngeal papilloma using a screening test.
Makiyama K; Hirai R; Matsuzaki H; Ikeda M
J Voice; 2013 Mar; 27(2):230-5. PubMed ID: 23273988
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media.
Jang D; Ratnam S; Smieja M; Speicher DJ; Arias M; Clavio A; Costescu D; Elit L; Huang S; Herrero-Garcia E; Joseph AM; Jiang H; Needle R; Chernesky M
Tumour Virus Res; 2021 Dec; 12():200224. PubMed ID: 34242835
[TBL] [Abstract][Full Text] [Related]
17. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
[TBL] [Abstract][Full Text] [Related]
18. Performance analysis of high-throughput HPV testing on three automated workflows.
Loonen AJM; Huijsmans CJJ; Geurts-Giele WRR; Leeijen C; van der Linden JC; van den Brule AJC
APMIS; 2020 Aug; 128(8):497-505. PubMed ID: 32562292
[TBL] [Abstract][Full Text] [Related]
19. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of MY09/11 consensus PCR in the detection of multiple HPV infections.
Şahiner F; Kubar A; Gümral R; Ardıç M; Yiğit N; Şener K; Dede M; Yapar M
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):43-9. PubMed ID: 24953539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
